SCHEMBL319693

SCHEMBL319693

CCN1CCCC(NC(=O)OC(C)(C)C)C1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 1/20 0.56
F10 P00742 1/20 0.56
PRSS1 P07477 1/20 0.56
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
CTSK P43235 2/20 0.39
BTK Q06187 1/20 0.39
MMP1 P03956 2/20 0.39
MMP3 P08254 2/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TSHR P16473 1/20 0.38
FPR2 P25090 1/20 0.38
SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL319691 1.00 F2 (0.56) F2F10PRSS1CA1CA2
SCHEMBL21165916 0.96 F2 (0.53) F2F10PRSS1CA1CA2
SCHEMBL10264999 0.92 F2 (0.47) F2F10PRSS1CA1CA2
SCHEMBL15130652 0.90 F2 (0.54) F2F10PRSS1CA1CA2
SCHEMBL203868 0.87 F2 (0.59) F2F10PRSS1CA1CA2
SCHEMBL13259958 0.87 F2 (0.59) F2F10PRSS1CA1CA2
SCHEMBL203869 0.87 F2 (0.59) F2F10PRSS1CA1CA2
SCHEMBL2707140 0.87 F2 (0.59) F2F10PRSS1CA1CA2
SCHEMBL13464988 0.86 MMP1 (0.43) F2F10PRSS1GAAL3MBTL1
SCHEMBL24263439 0.86 F2 (0.53) F2F10PRSS1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585447-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS Vertex Pharmaceuticals Incorporated (US) 2013-05-01 EP disclosed
WO-2012006055-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-01-12 WO disclosed